Search
for
Sort by
Research 91–120 of 252
- Patient reported androgen driven phenotypes do not associate with biochemical recurrence after radical prostatectomy
- MP44-04 TRENDS IN 5-ALPHA REDUCTASE INHIBITOR USE BEFORE AND AFTER THE FOOD AND DRUG ADMINISTRATION SAFETY WARNING
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II
- French administrative health care database (SNDS): The value of its enrichment
- Case-Only Trees and Random Forests for Exploring Genotype-Specific Treatment Effects in Randomized Clinical Trials with Dichotomous End Points
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Editorial Comment
- IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
- Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient
- Study Answers Some Questions about Androgen Suppression Pre-Radiation, but Not All
- PCPT Results Could Affect Trial on Testosterone Replacement
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?
- Why would men use finasteride in 2005?
- The Risk of Benign Prostatic Hyperplasia and Prostate Cancer With Long-Term, Low Dose Finasteride Use in Adult Men with Nonscarring Alopecia: A Propensity-Matched Observational Study
- Hormonal manipulation of benign prostatic hyperplasia
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- New fluorogenic probes for neutral and alkaline ceramidases
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Prostate Cancer Early Detection, Version 2.2015
- Long-Term Differential Changes in Mouse Intestinal Metabolomics after γ and Heavy Ion Radiation Exposure
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Scientific opinion on the tolerable upper intake level for selenium
- Male pattern baldness and prostate cancer risk in a population-based case–control study
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Androgenetic alopecia – Current status